Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-009192

OncoMed Pharmaceuticals Inc · OMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 7:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Feb 24, 2015J43,022$0.00A86,043IBy Adams Street Partnership Fund - 2002 U.S. Fund, L.P.
Common StockF3Feb 24, 2015J18,278$0.00A36,556IBy Adams Street Partnership Fund - 2003 U.S. Fund, L.P.
Common StockF4Feb 24, 2015J14,119$0.00A28,237IBy Adams Street Partnership Fund - 2004 U.S. Fund, L.P.
Common StockF5Feb 24, 2015J19,667$0.00A39,334IBy Adams Street Partnership Fund - 2005 U.S. Fund, L.P.
Common StockF6Feb 24, 2015J1,166$0.00A2,332IBy Brinson Partnership Fund-2004 Primary Fund, L.P.
Common StockF7Feb 24, 2015J782$0.00A1,564IBy The 2004 Primary Brinson Partnership Fund Offshore Series Company Ltd.
Common StockF8Feb 24, 2015J2,432$0.00A4,863IBy UBS Global Asset Management Trust Company as Trustee of the Brinson Partnership Fund Trust- 2004
Common StockF9Feb 24, 2015J27,218$0.00A57,764IBy The Bank of New York Mellon as Trustee for the Hewlett-Packard Company Master Trust
Common StockF10Feb 24, 2015J11,135$0.00A28,386IBy Brinson Partnership Fund-2001 Primary Fund, L.P.
Common StockF11Feb 24, 2015J8,499$0.00A21,665IBy The 2001 Primary Brinson Partnership Fund Offshore Series Company Ltd.
Common StockF12Feb 24, 2015J26,762$0.00A68,224IBy UBS Global Asset Management Trust Company as Trustee of the Brinson Partnership Fund Trust- 2001
Common StockF13Feb 24, 2015J3,555$0.00A9,107IBy Orange County Employees Retirement System
Common StockF14Feb 24, 2015J17,775$0.00A44,872IBy State Universities Retirement System Private Trust I
Common StockF15holding———641,750IBy Adams Street 2006 Direct Fund, L.P.
Common StockF16holding———592,953IBy Adams Street V, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses